Why SEMDA 2017 is a value-based investment for large medical device and medtech companies
We know well how many healthcare conferences with which SEMDA competes for attendees’ attention, time and treasure particularly for those representing large medical device and technology companies. Here are the top reasons SEMDA provides value for attendees and partners like your peers at Johnson & Johnson Innovation, Medtronic and Halyard.
Tour the entire Southeast medtech ecosystem in less than two days
Scores of young companies attend SEMDA every year and 2017 is no different. We have young, investable companies from a geographic area the size of Germany all descending on Atlanta April 26 and 27. We are pulling them out of Huntsville, Orlando, Savannah, Memphis and beyond so that you can meet them all in the same place at the same time. Each of the SEMDA PitchRounds Roadshow winners like Intent Solutions and Myolyn will attend and pitch for a chance at a $50,000 prize.
Beyond the innovators, you could meet your next strategic partner capable of bringing young medtech companies successfully from concept to commercialization. GCMI, the Global Center for Medical Innovation, is an outstanding example of this. GCMI recently announced the foundation and first strategic partner (BD) in a new medtech accelerator. We are grateful to GCMI and the balance of our sponsors for the support they provide that enables us to bring the Southeast medtech ecosystem together.
A highly engaged and accessible leadership team
I am immensely proud of the board of directors to whom I report. They are engaged and exhibit a high level of accessibility. You have the chance to mine hundreds of years of medtech experience by connecting with them in a concentrated forum at SEMDA 2017.
Access the Southeast medtech ecosystem efficiently at SEMDA 2017
Bob Crutchfield has said, “There are lots of conferences that compete for the wallet today. SEMDA is linking ‘strategics’ with vice presidents of research for many universities, connecting entrepreneurs with corporate development representatives and licensing groups at universities, fostering more acceleration of innovation. In terms of ‘bang for the buck,’ SEMDA is a good value and touches a lot of folks in healthcare performance and commercialization.”
Medtech innovation does belong to any one city, state or region. It exists across the country and often hides in some small pockets. There is excellent technology here. There are excellent support systems and infrastructure. It’s difficult to freely see the breadth of regional medtech innovation if you try to do it on your own. We give you the opportunity to do it all in less than two days. Get out of your local silo and see what’s happening throughout the Southeast – this is your only annual chance to do it. SEMDA 2017 makes it easy.